FIASP FLEXTOUCH insulin aspart (rys) 100 units/mL solution for injection 3 mL

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Mar 2025

RYZODEG 70/30 FLEXTOUCH 70% insulin degludec (rys) / 30% insulin aspart (rys) 100 U/mL solution for injection cartridge

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Feb 2025

Levophed 1:1000 noradrenaline (norepinephrine) 4mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024

CIPLA LENALIDOMIDE lenalidomide 5 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

CIPLA LENALIDOMIDE lenalidomide 10 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

CIPLA LENALIDOMIDE lenalidomide 15 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

CIPLA LENALIDOMIDE lenalidomide 25 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Dec 2024

MAYZENT siponimod 0.25 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 May 2025

OLANZAPINE ODT GENERICHEALTH 10 olanzapine 10 mg

Availability: Unavailable Deletion from market: 31 Jul 2024

LUKAIR montelukast (as sodium) 10 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 30 Apr 2026

DBL BORTEZOMIB 2.5 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024

DBL Bortezomib bortezomib 1.0 mg

Availability: Reduction in supply until supply is exhausted Deletion from market: 01 Oct 2024